vimarsana.com

Page 39 - Contracts And Orders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kingswood Capital Management to Acquire Senture, a Leading Provider of Multi-Channel Contact Center Solutions

Press release content from PR Newswire. The AP news staff was not involved in its creation. Kingswood Capital Management to Acquire Senture, a Leading Provider of Multi-Channel Contact Center Solutions January 21, 2021 GMT LONDON, Ky., Jan. 21, 2021 /PRNewswire/ Kingswood Capital Management, LP (together with its affiliates, “Kingswood”) announced today that it has signed a definitive agreement to acquire Senture, LLC (“Senture” or the “Company”) from the Company’s current shareholders. The acquisition is anticipated to close during the first quarter of 2021. Founded in 2003, Senture is an industry-leading, provider of multi-channel contact center solutions to government agencies, commercial customers, and large system integrators. The Company’s combination of flexible technology, proprietary training, dedicated staff, and speedy response to the COVID-19 pandemic enabled it to further accelerate its significant growth trajectory in recent years throughout the co

Bluma Wellness Inc Provides End-of-Month Operations Update and Financial Highlights for December 2020

Perini Management Services, Inc Announces Two Federal Contracts Collectively Valued at $66 9 Million

Press release content from Business Wire. The AP news staff was not involved in its creation. Perini Management Services, Inc. Announces Two Federal Contracts Collectively Valued at $66.9 Million January 20, 2021 GMT FRAMINGHAM, Mass. (BUSINESS WIRE) Jan 20, 2021 Tutor Perini Corporation (NYSE: TPC) (the “Company”), a leading civil, building and specialty construction company, today announced that its subsidiary, Perini Management Services, Inc. (PMSI), has recently been awarded two fixed-price federal contracts collectively valued at approximately $66.9 million. Design-Build Pre-Fabricated Dormitory, Federal Law Enforcement Training Centers (FLETC), Glynco, Georgia PMSI received a $40.9 million task order contract under the Homeland Security National Multiple Award Construction Contract II (NMACC II). The project includes the design and construction of a dormitory that will be built utilizing modular construction methods. This will be PMSI’s third task order at the Glyn

SōRSE Technology Enters into Distribution Agreement with Medara S A to Increase Accessibility of Water-Soluble Cannabinoids in Latin America

Press release content from Business Wire. The AP news staff was not involved in its creation. SōRSE Technology Enters into Distribution Agreement with Medara S.A. to Increase Accessibility of Water-Soluble Cannabinoids in Latin America January 19, 2021 GMT SōRSE Technology (“SōRSE”), a water-soluble emulsion technology company based in Seattle, WA, U.S., and Medara S.A. (“Medara”), a company based in Montevideo, Uruguay, proudly announce the commercial agreement signed by both companies for the distribution of SōRSE’s products in the South Cone. With this agreement, SōRSE will work hand in hand with Medara to educate Latin American consumers on the benefits of products that utilize water-soluble emulsion technology to deliver accurate dosing of cannabinoids with full certifications.

PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation

Press release content from Globe Newswire. The AP news staff was not involved in its creation. PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation . Newscope Capital CorporationJanuary 19, 2021 GMT TORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. (“PharmaTher”), is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that PharmaTher has entered into an Exclusive Worldwide License Agreement (the “Agreement”) with the National Health Research Institutes (“NHRI”) for the development and commercialization of a patented combination formulation of FDA-approved ketamine and betaine (“KETABET™”) as a potential next-generation ketamine treatment for mental health, neurological and pain disorders.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.